The opening of the trial can be a landmark for ACCRU, a network greater than 85 academic and community cancers centers throughout the United Canada and Says. This trial is relatively unique since it can be investigator-initiated, industry-sponsored, and being conducted within the ACCRU network solely. This is a genuine collaboration between a pharmaceutical business and academic and community tumor centers with the primary goal of conducting clinical research to improve patient treatment, Dr. Liu says. Related StoriesSausages With Antioxidants From Berries TO AVOID CancerMD Anderson study reveals why chemotherapy medications not effective for most pancreatic cancer patientsStudy shows rare HER2 missense mutations do not spread breast cancer on their own The opening of this trial showcases ACCRU's network capabilities to carry out a large, multicenter trial which includes well-designed translational study that will provide important information for all physicians selecting treatments for patients with metastatic breast tumor, says Axel Grothey, M.D., ACCRU group oncologist and chair at Mayo Clinic.Aristotle believed that pleasure was the best good – the best good, the supreme good. This definition, though, comes into clearer focus whenever we understand that Aristotle considered pleasure as a state of human being well-getting that leaves nothing more to be desired. A happy man, Aristotle would say, is the man who has everything he needs – not what he wants actually, but what he demands. He has those plain things that he must realize his full individual potential.